Cingulate Inc. (NASDAQ:CINGW) Sees Large Growth in Short Interest

Cingulate Inc. (NASDAQ:CINGW) was the target of a large growth in short interest in the month of December. As of December 31st, there was short interest totaling 1,819 shares, a growth of 127.4% from the December 15th total of 800 shares. Based on an average daily trading volume, of 26,172 shares, the short-interest ratio is presently 0.1 days. Based on an average daily trading volume, of 26,172 shares, the short-interest ratio is presently 0.1 days.

Cingulate Stock Up 13.6%

Cingulate stock traded up $0.01 during trading hours on Friday, hitting $0.11. The company had a trading volume of 15,269 shares, compared to its average volume of 77,188. The firm has a 50-day moving average of $0.05 and a 200 day moving average of $0.06. Cingulate has a one year low of $0.02 and a one year high of $0.18.

About Cingulate

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.